{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Synthetic replication via swaps",
        "Daily reset and compounding effects",
        "Counterparty risk",
        "Collateralised debt security structure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree DAX 3x Daily Leveraged product is a fully collateralised, UCITS eligible Exchange Traded Product (ETP) that provides 3x leveraged exposure to the DAX index through a synthetic replication method using total return swaps. The product explicitly uses swaps as the underlying mechanism to achieve its investment objective, confirmed by references to 'fully collateralised swap', 'swap counterparties', and 'swap agreements'. The leverage factor is 3x daily, with daily reset and compounding effects, which introduces complexity in understanding returns over periods longer than one day. The product is structured as a collateralised debt security, not as a traditional ETF, and is not UCITS compliant (despite being UCITS eligible). The risk profile is the highest possible (7/7), indicating very high risk and complexity. The KIID and PRIIPs documents warn that the product is not simple, requires specific knowledge, and is intended for informed investors who understand leverage, daily rebalancing, and compounding. There is significant counterparty risk mitigated by collateral held at a third party custodian, but this adds to complexity. The product also involves costs related to maintaining the leveraged position and swap fees. The daily reset and compounding effects mean that returns over longer periods do not linearly track the underlying index multiplied by three, which is a complexity factor for retail investors. Overall, the use of leverage, synthetic replication via swaps, counterparty risk, and the product structure as a collateralised debt security all contribute to the classification as a complex financial instrument under MiFID II."
}